Qiagen NV Target Price

See Qiagen NV's analyst price targets ($41) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$43.39

Average Target Price

$41.44

4.5% downside

7 analysts in the last 4 months

High: $48 | Low: $36

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Stifel NicolausDaniel Arias	$40	7.8% downside
2026-08-07	Barclays	$40	7.8% downside
2026-08-06	Jefferies	$48	10.6% upside
2026-07-14	Berenberg BankHarry Gillis	$45.5	4.9% upside
2026-06-25	Kepler Capital	$38.6	11% downside
2026-06-23	Morgan Stanley	$42	3.2% downside
2026-05-18	Stifel Nicolaus	$36	17% downside
2026-04-30	Deutsche BankJan Koch	$43	0.9% downside
2026-04-29	BarclaysLuke Sergott	$38	12.4% downside
2026-04-29	Robert W. Baird	$43	0.9% downside
2026-04-14	Barclays	$44	1.4% upside
2026-02-09	UBS	$52	19.8% upside
2026-02-06	Robert W. BairdCathy Ramsey Schulte	$53	22.1% upside
2026-02-06	Stifel Nicolaus	$50	15.2% upside
2026-02-06	Barclays	$58	33.7% upside
2026-02-05	Jefferies	$59	36% upside
2026-01-22	Deutsche BankJan Koch	$54	24.5% upside
2025-12-15	Barclays	$57.89	33.4% upside
2025-10-02	BarclaysCatherine Ramsey Schulte	$55.79	28.6% upside
2024-10-17	HSBCShubhangi Gupt	$51.58	18.9% upside
2024-06-27	Wolfe ResearchDoug Schenkel	$52.63	21.3% upside
2024-06-18	UBSJohn Sourbeer	$48.42	11.6% upside
2021-11-04	Cowen & Co.Daniel Brennan	$61.05	40.7% upside
2021-07-15	Bank of America SecuritiesDerik De Bruin	$54.74	26.2% upside
2021-07-14	CitigroupPatrick B Donnelly	$61.05	40.7% upside
2021-07-13	Warburg ResearchUlrich Huwald	$52.89	21.9% upside

Qiagen NV (QGEN) FAQ

The latest target price for QGEN is $41. Investors often review this figure alongside Qiagen NV's historical trend and sector peers before judging valuation or financial health.

Qiagen NV trades near $43.39 while the consensus target sits at $41 (4.5% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting QGEN's target price ($41), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Qiagen NV's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.